Today is August 19, 2024.
All times in Eastern Daylight Time.
-
Summit Therapeutics to Host Second Quarter 2024 Financial Results & Operational Progress Call on August 6, 2024
MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) will host an earnings call to announce its second quarter 2024 financial results and provide an op... more »
-
Hess Midstream LP Announces Distribution Per Share Level Increase
HOUSTON--(BUSINESS WIRE)--HESS MIDSTREAM LP ANNOUNCES DISTRIBUTION PER SHARE LEVEL INCREASE more »
-
Fluor Awarded Contract for Next Phase of Engineering and Design for Small Modular Reactor Power Plant in Romania
IRVING, Texas--(BUSINESS WIRE)--Fluor Awarded Contract for Next Phase of Engineering and Design for Small Modular Reactor Power Plant in Romania more »
-
Vicarious Surgical to Report Second Quarter 2024 Financial Results on August 12, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives throug... more »
-
PotlatchDeltic Corporation Reports Second Quarter 2024 Results
SPOKANE, Wash.--(BUSINESS WIRE)--PotlatchDeltic Corporation (Nasdaq: PCH) today reported net income of $13.7 million, or $0.17 per diluted share, on revenues of $320.7 million for the quarter ended... more »
-
Crescent Stockholders Overwhelmingly Approve Merger with SilverBow Resources
HOUSTON--(BUSINESS WIRE)--Crescent Energy Company (NYSE: CRGY) (“Crescent” or the “Company”), today announced it received overwhelming stockholder approval for the issuance of Crescent Class A comm... more »
-
NeoGenomics Reports Second Quarter 2024 Results
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced its second-quarter results for the period ended June 30, 2024. more »
-
Cushman & Wakefield Reports Financial Results for the Second Quarter 2024
CHICAGO--(BUSINESS WIRE)--Cushman & Wakefield (NYSE: CWK) today reported financial results for the second quarter of 2024. “Our solid second quarter results, highlighted by our third consecutiv... more »
-
NETSTREIT Reports Second Quarter 2024 Financial and Operating Results
DALLAS--(BUSINESS WIRE)--NETSTREIT Corp. (NYSE: NTST) (the “Company”) today announced financial and operating results for the second quarter ended June 30, 2024. “I am pleased to report we complete... more »
-
SilverBow Resources Stockholders Approve Acquisition by Crescent Energy
HOUSTON--(BUSINESS WIRE)--SilverBow Resources, Inc. (NYSE: SBOW) (“SilverBow” or the “Company”) today announced that, at a special meeting of stockholders earlier today (the “Special Meeting”), its... more »
-
AMERISAFE Announces 2024 Second Quarter Results
DERIDDER, La.--(BUSINESS WIRE)--AMERISAFE ANNOUNCES 2024 SECOND QUARTER RESULTS more »
-
Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024
MIAMI--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced it will report ... more »
-
Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that it has received New Drug Application (“NDA”) approval from the U.S. ... more »
-
CEL-SCI Announces Closing of $10.8 Million Offering
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI announces closing of $10.8 million offering. more »
-
Caliber Announces Second Quarter 2024 Earnings Release and Conference Call
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Caliber to issue its second quarter 2024 earnings report on August 12, 2024. more »
-
NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company” or “NovaBay”) today announced the closing of its previously announced underwritten public offe... more »
-
F5 Reports Third Quarter Fiscal Year 2024 Revenue at the Top End of its Guidance Range; Expects Fiscal Year 2024 Revenue of ~$2.8 Billion Based on Software Strength; Raises Earnings Growth Outlook
SEATTLE--(BUSINESS WIRE)--F5, Inc. (NASDAQ: FFIV) today announced financial results for its third quarter ended June 30, 2024. “We delivered third quarter revenue at the top end of our guidance ran... more »
-
Central Garden & Pet to Announce Q3 Fiscal 2024 Financial Results
WALNUT CREEK, Calif.--(BUSINESS WIRE)--Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA) (“Central”), a market leader in the Pet and Garden industries, will announce results for its f... more »
-
Amkor Technology Reports Financial Results for the Second Quarter 2024
TEMPE, Ariz.--(BUSINESS WIRE)--Amkor Technology Reports Financial Results for the Second Quarter 2024 more »
-
HomeStreet Reports Second Quarter 2024 Results
SEATTLE--(BUSINESS WIRE)--HomeStreet Reports Second Quarter 2024 Results more »
-
Rambus Expands Industry-Leading Memory Interface Chip Offering to High-Performance PCs with DDR5 Client Clock Driver
SAN JOSE, Calif.--(BUSINESS WIRE)--Today, Rambus announced the availability of its DDR5 Client Clock Driver (CKD) for next-generation, high-performance desktops and notebooks. more »
-
Sprouts Farmers Market, Inc. Reports Second Quarter 2024 Results
PHOENIX--(BUSINESS WIRE)--Sprouts Farmers Market, Inc. (Nasdaq: SFM) today reported results for the 13-week second quarter ended June 30, 2024. "Sprouts saw outstanding second quarter results, than... more »
-
SBA Communications Corporation Reports Second Quarter 2024 Results; Updates Full Year 2024 Outlook; and Declares Quarterly Cash Dividend
BOCA RATON, Fla.--(BUSINESS WIRE)--SBA Communications Corporation (Nasdaq: SBAC) ("SBA" or the "Company") today reported results for the quarter ended June 30, 2024. Highlights of the second quarte... more »
-
ATSG Delivers Two Boeing 767s to Georgian Airways
WILMINGTON, Ohio--(BUSINESS WIRE)--ATSG announced today that its leasing subsidiary recently delivered two Boeing 767-300 aircraft to Georgian Airways LLC of Tbilisi, Georgia. more »
-
Verastem Oncology Receives FDA Orphan Drug Designation for Avutometinib and Defactinib for the Treatment of Pancreatic Cancer
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients, today announced that the U.S. Food and Drug Administration ... more »
|
|